These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32887025)

  • 1. NCK1-AS1 enhances glioma cell proliferation, radioresistance and chemoresistance via miR-22-3p/IGF1R ceRNA pathway.
    Wang B; Wang K; Jin T; Xu Q; He Y; Cui B; Wang Y
    Biomed Pharmacother; 2020 Sep; 129():110395. PubMed ID: 32887025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NCK1-AS1 Increases Drug Resistance of Glioma Cells to Temozolomide by Modulating miR-137/
    Chen M; Cheng Y; Yuan Z; Wang F; Yang L; Zhao H
    Cancer Biother Radiopharm; 2020 Mar; 35(2):101-108. PubMed ID: 31750728
    [No Abstract]   [Full Text] [Related]  

  • 3. Long non-coding RNA NCK1-AS1 promotes the tumorigenesis of glioma through sponging microRNA-138-2-3p and activating the TRIM24/Wnt/β-catenin axis.
    Huang L; Li X; Ye H; Liu Y; Liang X; Yang C; Hua L; Yan Z; Zhang X
    J Exp Clin Cancer Res; 2020 Apr; 39(1):63. PubMed ID: 32293515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of lncRNA HOXD-AS1 suppresses proliferation, migration and invasion and enhances cisplatin sensitivity of glioma cells by sponging miR-204.
    Zhou H; Ma Y; Zhong D; Yang L
    Biomed Pharmacother; 2019 Apr; 112():108633. PubMed ID: 30784927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA NCK1-AS1 exerts oncogenic property in gastric cancer by targeting the miR-22-3p/BCL9 axis to activate the Wnt/β-catenin signaling.
    Guan B; Ma J; Yang Z; Yu F; Yao J
    Environ Toxicol; 2021 Aug; 36(8):1640-1653. PubMed ID: 33974352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA NCK1-AS1 Aggravates Hepatocellular Carcinoma by the miR-22-3p/YARS Axis to Activate PI3K/AKT Signaling.
    Zhou W; Wang J; Zhang J; Wang Y; Jiang L; Guo T; Luo B; Xu Q; Huang Y
    J Gastrointestin Liver Dis; 2022 Mar; 31(1):48-59. PubMed ID: 35306563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
    Li C; Feng S; Chen L
    Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NCK1-AS1 promotes NCK1 expression to facilitate tumorigenesis and chemo-resistance in ovarian cancer.
    Chang H; Li B; Zhang X; Meng X
    Biochem Biophys Res Commun; 2020 Feb; 522(2):292-299. PubMed ID: 31761329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA NCK1-AS1 promotes proliferation and induces cell cycle progression by crosstalk NCK1-AS1/miR-6857/CDK1 pathway.
    Li H; Jia Y; Cheng J; Liu G; Song F
    Cell Death Dis; 2018 Feb; 9(2):198. PubMed ID: 29416014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review on the role of NCK1 Antisense RNA 1 (NCK1-AS1) in diverse disorders.
    Taheri M; Askari A; Behzad Moghadam K; Hussen BM; Ghafouri-Fard S; Kiani A
    Pathol Res Pract; 2023 May; 245():154451. PubMed ID: 37028107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA PSMA3-AS1 enhances cell proliferation, migration and invasion by regulating miR-302a-3p/RAB22A in glioma.
    Zhou LL; Zhang M; Zhang YZ; Sun MF
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32894281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of long noncoding RNA NCK1-AS1 increases chemosensitivity to cisplatin in cervical cancer.
    Zhang WY; Liu YJ; He Y; Chen P
    J Cell Physiol; 2019 Apr; 234(4):4302-4313. PubMed ID: 30221354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Long Noncoding RNA TP73-AS1 Interacted with miR-124 to Modulate Glioma Growth by Targeting Inhibitor of Apoptosis-Stimulating Protein of p53.
    Xiao S; Wang R; Wu X; Liu W; Ma S
    DNA Cell Biol; 2018 Feb; 37(2):117-125. PubMed ID: 29412778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUMOylation of IGF2BP2 promotes vasculogenic mimicry of glioma via regulating OIP5-AS1/miR-495-3p axis.
    Li H; Wang D; Yi B; Cai H; Wang Y; Lou X; Xi Z; Li Z
    Int J Biol Sci; 2021; 17(11):2912-2930. PubMed ID: 34345216
    [No Abstract]   [Full Text] [Related]  

  • 15. LncRNA NNT-AS1 promote glioma cell proliferation and metastases through miR-494-3p/PRMT1 axis.
    Zheng D; Chen D; Lin F; Wang X; Lu L; Luo S; Chen J; Xu X
    Cell Cycle; 2020 Jul; 19(13):1621-1631. PubMed ID: 32420808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA SOX21-AS1 promotes cell proliferation and invasion through upregulating PAK7 expression by sponging miR-144-3p in glioma cells.
    Gai SY; Yuan ZH
    Neoplasma; 2020 Mar; 67(2):333-343. PubMed ID: 31973536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA OIP5-AS1 targets Wnt-7b to affect glioma progression via modulation of miR-410.
    Sun WL; Kang T; Wang YY; Sun JP; Li C; Liu HJ; Yang Y; Jiao BH
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30498093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Long Non-Coding RNA TP73-AS1 Interacted With miR-142 to Modulate Brain Glioma Growth Through HMGB1/RAGE Pathway.
    Zhang R; Jin H; Lou F
    J Cell Biochem; 2018 Apr; 119(4):3007-3016. PubMed ID: 28379612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA NCK1-AS1 Promotes Malignant Cellular Phenotypes of Laryngeal Squamous Cell Carcinoma via miR-137/NCK1 Axis.
    Wan L; Gu D; Jin X
    Mol Biotechnol; 2022 Aug; 64(8):888-901. PubMed ID: 35218517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long Non-coding RNA COX10-AS1 Promotes Glioma Progression by Competitively Binding miR-1-3p to Regulate ORC6 Expression.
    Zhang G; Tao X; Ji BW; Gong J
    Neuroscience; 2024 Mar; 540():68-76. PubMed ID: 38244670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.